T cell senescence occurs in the TME, affecting cancer prognosis and immunotherapy efficacy. The TME induces T cell senescence ...

The cancer drugs called PARP inhibitors have a puzzling reputation: even though they are treatment mainstays for multiple ...

Lab grown models of embryos, made from clusters of stem cells, are getting increasingly complex. Ethicists, regulators and ...

He made a conceptual leap in immunotherapy by creating a hybrid T-cell, known as CAR-T, that was genetically modified to ...

Researchers have discovered a way to make the immune system's T cells significantly more effective at fighting cancer. By ...

A small but enthusiastic group of neuroscientists is exhuming overlooked experiments and performing new ones to explore ...

New designer proteins created using an AI tool can selectively target peptide segments that bind to markers on diseased ...

Corona and flu infections may play a role in the recurrence of cancer in previously recovered patients. The viruses have been ...

Imagine your immune cells could be modified to attack any kind of cancer. T cell receptor (TCR) therapy has the potential to ...

Advanced light microscopy techniques are giving scientists a new understanding of human biology and what goes wrong in ...

A common plant virus awakens the immune system to fight cancer—and it’s grown using sunlight, soil, and science.

MaxCyte’s Flow Electroporation® Technology will support non-viral gene editing in the manufacture of Anocca’s TCR-T cell therapies ...